Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Abacavir Sulfate, and when can generics launch?

Abacavir Sulfate is a drug marketed by Hetero Labs Ltd Iii, Aurobindo Pharma Ltd, Strides Pharma, Apotex Inc, Mylan Pharms Inc, Cipla Ltd, Teva Pharms Usa, and Lupin Ltd. and is included in eleven NDAs.

The generic ingredient in ABACAVIR SULFATE is abacavir sulfate; lamivudine; zidovudine. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the abacavir sulfate; lamivudine; zidovudine profile page.

Summary for Tradename: ABACAVIR SULFATE

Suppliers / Packagers: see list11
Bulk Api Vendors: see list72
Clinical Trials: see list311
Patent Applications: see list4,213
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ABACAVIR SULFATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hetero Labs Ltd Iii
abacavir sulfate
SOLUTION;ORAL201107-001Sep 26, 2016AARXNoNo► Subscribe► Subscribe
Cipla Ltd
abacavir sulfate; lamivudine
TABLET;ORAL091144-001Mar 28, 2017ABRXNoNo► Subscribe► Subscribe
Hetero Labs Ltd Iii
abacavir sulfate
TABLET;ORAL091560-001Sep 13, 2013ABRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
abacavir sulfate; lamivudine
TABLET;ORAL079246-001Sep 29, 2016ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
abacavir sulfate
TABLET;ORAL077844-001Dec 17, 2012ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus